» Articles » PMID: 29891880

A Theory-informed Systematic Review of Clinicians' Genetic Testing Practices

Overview
Journal Eur J Hum Genet
Specialty Genetics
Date 2018 Jun 13
PMID 29891880
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

This systematic literature review investigates factors impacting on clinicians' decisions to offer genetic tests in their practice, and maps them to a theoretical behaviour change framework. Better understanding of these factors will inform the design of effective interventions to integrate genomics tests into clinical care. We conducted a narrative synthesis of empirical research of medical specialists' perspectives on and experiences of offering genetic tests to their patients. This review was based upon the PRISMA statement and guidelines for reviewing qualitative research. Four electronic data sources were searched-MEDLINE, EMBASE, CINAHL, PubMed. Studies were independently assessed by two authors. Content analysis was applied to map the findings of included studies to a framework validated for behaviour and implementation research, the Theoretical Domains Framework (TDF). The TDF describes 14 factors known to influence behaviour and has been applied in diverse clinical settings to understand and/or modify health professional behaviour. Thirty-four studies published in 39 articles met inclusion and quality criteria. Most studies were published after 2011 (54%), Northern American (82%), quantitative in design (68%) and addressed familial cancer genetic tests (53%). Of the 14 TDF factors, 13 were identified. The three most common factors were: Environmental Context and Resources (n = 33), Beliefs about Consequences (n = 26), and Knowledge (n = 23). To support the adoption of genomic tests beyond specialist services, nuanced interventions targeting considerations beyond clinician education are needed. For instance, interventions addressing organisational constraints which may restrict clinicians' ability to offer genomic tests are required alongside those targeting factors intrinsic to the clinician.

Citing Articles

Phenotype driven molecular genetic test recommendation for diagnosing pediatric rare disorders.

Chen F, Ahimaz P, Nguyen Q, Lewis R, Chung W, Ta C NPJ Digit Med. 2024; 7(1):333.

PMID: 39572625 PMC: 11582592. DOI: 10.1038/s41746-024-01331-1.


Survey of the Landscape of Society Practice Guidelines for Genetic Testing of Neurodevelopmental Disorders.

Srivastava S, Cole J, Cohen J, Chopra M, Smith H, Deardorff M Ann Neurol. 2024; 96(5):900-913.

PMID: 39319594 PMC: 11496025. DOI: 10.1002/ana.27045.


Genomics in nephrology: identifying informatics opportunities to improve diagnosis of genetic kidney disorders using a human-centered design approach.

Romagnoli K, Salvati Z, Johnson D, Ramey H, Chang A, Williams M J Am Med Inform Assoc. 2024; 31(6):1247-1257.

PMID: 38497946 PMC: 11105128. DOI: 10.1093/jamia/ocae053.


Phenotype-Driven Molecular Genetic Test Recommendation for Diagnosing Pediatric Rare Disorders.

Chen F, Ahimaz P, Wang K, Chung W, Ta C, Weng C Res Sq. 2023; .

PMID: 38045411 PMC: 10690317. DOI: 10.21203/rs.3.rs-3593490/v1.


Genetic testing and gene therapy in retinal diseases: Knowledge and perceptions of optometrists in Australia and New Zealand.

Britten-Jones A, Mack H, Vincent A, Hill L, Edwards T, Ayton L Clin Genet. 2023; 105(1):34-43.

PMID: 37553298 PMC: 10952375. DOI: 10.1111/cge.14415.


References
1.
Harris B, Miyake C, Motonaga K, Dubin A . Diagnosis and management of pediatric brugada syndrome: a survey of pediatric electrophysiologists. Pacing Clin Electrophysiol. 2014; 37(5):638-42. DOI: 10.1111/pace.12346. View

2.
Stark Z, Tan T, Chong B, Brett G, Yap P, Walsh M . A prospective evaluation of whole-exome sequencing as a first-tier molecular test in infants with suspected monogenic disorders. Genet Med. 2016; 18(11):1090-1096. DOI: 10.1038/gim.2016.1. View

3.
Manolio T, Abramowicz M, Al-Mulla F, Anderson W, Balling R, Berger A . Global implementation of genomic medicine: We are not alone. Sci Transl Med. 2015; 7(290):290ps13. PMC: 4898888. DOI: 10.1126/scitranslmed.aab0194. View

4.
Chase G, Geller G, Havstad S, Holtzman N, Bassett S . Physicians' propensity to offer genetic testing for Alzheimer's disease: results from a survey. Genet Med. 2002; 4(4):297-303. DOI: 10.1097/00125817-200207000-00008. View

5.
Vassy J, Christensen K, Schonman E, Blout C, Robinson J, Krier J . The Impact of Whole-Genome Sequencing on the Primary Care and Outcomes of Healthy Adult Patients: A Pilot Randomized Trial. Ann Intern Med. 2017; 167(3):159-169. PMC: 5856654. DOI: 10.7326/M17-0188. View